Anixa Biosciences, Inc. (ANIX)
3.11
-0.01
(-0.32%)
USD |
NASDAQ |
Dec 31, 09:48
Anixa Biosciences Total Assets (Quarterly): 17.65M for July 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.55B |
| Puma Biotechnology, Inc. | 202.86M |
| GT Biopharma, Inc. | 4.321M |
| Amneal Pharmaceuticals, Inc. | 3.600B |
| Lexeo Therapeutics, Inc. | 143.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.24M |
| Shareholders Equity (Quarterly) | 16.60M |
| Debt to Equity Ratio | 0.0128 |
| Current Ratio | 8.446 |
| Net Debt Paydown Yield | -0.01% |